Our investment philosophy

Whilst investing in the Biotechnology and Medical Technology sector can produce superior returns, its characteristics dictate that the way to generate the best risk adjusted returns is to:

  1. Take a portfolio approach to investing
  2. Have an adequate timeframe

Ideally investors should have a minimum of a 3 and preferably a 5 year time horizon for monies invested in HB Biotechnology portfolios to give the portfolio the best chance of achieving superior risk adjusted returns.

As a stock-picker, our focus will always be on identifying high quality, well run companies with superior assets in terms of their prospects, competent professional management, and adequate transparency.  Our investment universe encompasses Global Small to Mid Cap biotechnology and medical technology companies typically in the clinical development to early commercialisation phase.